Filing summary
Entity and period: The supplied filing is Global Medical REIT Inc. (NYSE: GMRE), not Chiron Real Estate Inc. It is the audited Form 10-K for the fiscal year ended December 31, 2022, filed March 1, 2023. The summary below reflects the filing text provided.
Business context and reporting period
GMRE is an internally managed REIT that acquires healthcare properties and leases them to physician groups and healthcare systems, generally under medium- to long-term leases. At year-end, its portfolio comprised 189 buildings, approximately 4.90 million leasable square feet, and $114.5 million in annualized base rent (ABR). Medical office buildings generated 67.8% of ABR; inpatient rehabilitation facilities generated 17.5%. Approximately 3.5% of leasable space was vacant.
Key financial metrics
| Metric | 2022 | 2021 |
|---|---|---|
| Total revenue | $137.3 million | $115.9 million |
| Net income | $20.0 million | $18.3 million |
| Net income attributable to common stockholders | $13.3 million; $0.20 per share | $11.8 million; $0.19 per share |
| FFO per share and unit | $0.92 | $0.90 |
| AFFO per share and unit | $0.98 | $0.95 |
| Net cash from operating activities | $76.5 million | $69.0 million |
| Net cash used in investing activities | $137.3 million | $194.7 million |
| Net cash from financing activities | $62.4 million | $127.7 million |
| Total debt, net | $694.1 million | $571.7 million |
| Weighted-average debt interest rate at year-end | 4.20% | 2.87% |
| Cash and restricted cash | $14.5 million, including $4.0 million unrestricted cash | $12.8 million |
| Common dividends per share | $0.84 | $0.82 |
Figures are reported in the filing; cash flow and balance-sheet amounts are rounded. FFO and AFFO are non-GAAP measures and should be read alongside GAAP results.
Material changes versus 2021
- Revenue increased $21.3 million, primarily from 14 acquisitions completed in 2022 and a full year of rent from 2021 acquisitions. Recoveries of property operating expenses also rose.
- Operating expenses increased $9.7 million; depreciation and amortization rose by a combined $9.8 million, reflecting portfolio growth. Interest expense rose $5.5 million to $25.2 million due to higher average borrowing and interest rates.
- Income before property-sale gains declined to $13.2 million from $17.3 million. A $6.8 million gain on a 2022 property sale, versus $1.1 million in 2021, contributed to higher reported net income.
- Debt increased by $122.4 million net, while the year-end weighted-average debt rate rose 1.33 percentage points. The company added a $150 million term loan, extended the revolver maturity, and transitioned facility borrowings from LIBOR to SOFR.
- Operating cash flow increased, while investing outflow decreased, partly because property investment activity was lower than in 2021. Financing cash inflow fell, reflecting lower equity proceeds.
Liquidity, debt and capital commitments
At December 31, 2022, the Credit Facility included $350 million Term Loan A, $150 million Term Loan B, and a $400 million revolver; the facility also has a $500 million accordion feature. The revolver balance was $145.7 million, and the company reported $245.0 million of unused borrowing capacity as of February 24, 2023. Term Loan A matures in May 2026, the revolver in August 2026 (with extension options), and Term Loan B in February 2028. Management said it believed the company complied with its debt covenants at year-end.
The company had approximately $30 million of capital improvement commitments and obligations at year-end, with about $10 million expected in the following 12 months. Stated 2023 principal and interest payments were approximately $30.5 million. The Series A preferred stock, with a $77.6 million liquidation preference and a 7.50% annual dividend rate, became eligible for redemption in September 2022; no shares had been redeemed by year-end.
Outlook, commentary, risks and unusual items
- Outlook: The filing provides no formal earnings or acquisition guidance. Management identified an aging population, increased outpatient care, and healthcare-provider consolidation as potential positive trends. Higher interest rates and inflation, labor costs, COVID-19 effects, and reimbursement pressure were identified as potential headwinds.
- Interest-rate exposure: The term loans were hedged with swaps, but $145.7 million of revolver borrowings were unhedged at year-end. The filing estimates that a 100-basis-point SOFR increase would reduce annual cash flow by about $1.5 million, assuming no change in floating-rate debt.
- Tenant and portfolio risk: The business depends on tenants’ ability to pay rent. Texas represented 17.6% of ABR; the top three tenant groups represented about 17.8% of ABR. Leases representing 6.6% of ABR expire in 2023 and 13.7% in 2024.
- Pipeline Health bankruptcy: Pipeline, the sole tenant at GMRE-owned White Rock Medical Center, filed for Chapter 11 in October 2022. Its reorganization plan provided for assumption of the leases, with amendments; that plan became effective for GMRE’s leases on February 6, 2023.
- Transactions: As of February 24, 2023, one acquisition for approximately $6.7 million was under contract and two property sales for approximately $11.6 million gross proceeds were under contract, all subject to due diligence and closing conditions. In July 2022, GMRE sold a medical office building for $17.9 million gross proceeds and recorded a $6.8 million gain.
- Accounting and audit: The auditor issued unqualified opinions on the financial statements and internal controls. Acquisition purchase-price allocation was identified as a critical audit matter involving significant valuation estimates. Management reported effective disclosure controls and internal control over financial reporting.
Important facts for investors to verify
- Confirm the issuer identity: the filing is for Global Medical REIT Inc. (GMRE), despite the request naming Chiron Real Estate Inc.
- Review current tenant credit, rent collection, and the continuing performance of White Rock Medical Center following Pipeline’s restructuring.
- Assess debt covenant headroom, floating-rate exposure, hedge coverage, and upcoming maturities against available liquidity and operating cash flow.
- Check whether the contracted acquisition and property sales closed, and whether capital commitments or lease expirations changed after the filing date.
- Evaluate dividend sustainability using cash flow, debt service, capital needs, and the preferred stock’s cumulative dividend and redemption terms; the board retains discretion over common dividends.
- Reconcile FFO and AFFO to GAAP results and consider the impact of property-sale gains, non-cash adjustments, and portfolio growth.